Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Early balding at 40 increases prostate cancer risk.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Some birth control pills have a higher risk of blood clots than others.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Women treated with X-ray for scalp fungus as children had a higher chance of hair loss, especially with higher radiation doses and severe fungus infections.

Topical minoxidil significantly increases hair growth in androgenetic alopecia but only some patients see cosmetically acceptable results.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.